Ashton Thomas Private Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
47,869
+2,101
| +5% | +$233K | 0.19% | 129 |
|
|
2025
Q1 | $5.13M | Buy |
45,768
+1,551
| +4% | +$174K | 0.2% | 127 |
|
|
2024
Q4 | $4.08M | Buy |
44,217
+932
| +2% | +$86.1K | 0.16% | 152 |
|
|
2024
Q3 | $3.63M | Sell |
43,285
-1,165
| -3% | -$97.7K | 0.19% | 133 |
|
|
2024
Q2 | $3.05M | Buy |
44,450
+818
| +2% | +$56.1K | 0.17% | 139 |
|
|
2024
Q1 | $3.2M | Sell |
43,632
-623
| -1% | -$45.6K | 0.18% | 145 |
|
|
2023
Q4 | $3.59M | Buy |
44,255
+75
| +0.2% | +$6.08K | 0.23% | 125 |
|
|
2023
Q3 | $3.31M | Buy |
44,180
+1,408
| +3% | +$106K | 0.24% | 119 |
|
|
2023
Q2 | $3.3M | Buy |
42,772
+1,617
| +4% | +$125K | 0.25% | 109 |
|
|
2023
Q1 | $3.41M | Sell |
41,155
-33,227
| -45% | -$2.76M | 0.3% | 84 |
|
|
2022
Q4 | $6.39M | Buy |
74,382
+1,010
| +1% | +$86.7K | 0.63% | 33 |
|
|
2022
Q3 | $4.53M | Buy |
73,372
+12,201
| +20% | +$753K | 0.51% | 42 |
|
|
2022
Q2 | $3.78M | Buy |
61,171
+12,420
| +25% | +$768K | 0.41% | 67 |
|
|
2022
Q1 | $2.9M | Buy |
48,751
+8,124
| +20% | +$483K | 0.25% | 113 |
|
|
2021
Q4 | $2.95M | Buy |
40,627
+22,157
| +120% | +$1.61M | 0.29% | 93 |
|
|
2021
Q3 | $1.29M | Buy |
18,470
+375
| +2% | +$26.2K | 0.19% | 124 |
|
|
2021
Q2 | $1.25M | Buy |
18,095
+7,647
| +73% | +$527K | 0.19% | 131 |
|
|
2021
Q1 | $675K | Buy |
+10,448
| New | +$675K | 0.11% | 196 |
|